The metal-responsive transcription factor-1 protein is elevated in human tumors

27Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We previously identified metal-responsive transcription factor-1 (MTF-1) as a positive contributor to mouse fibrosarcoma growth through effects on cell survival, proliferation, tumor angiogenesis and extracellular matrix remodeling. In the present study, we investigated MTF-1 protein expression in human tissues by specific immunostaining of both normal and tumor tissue samples. Immunohistochemical (IHC) staining of a human tissue microarray (TMA), using a unique antihuman MTF-1 antibody, indicated constitutive MTF-1 expression in most normal tissues, with liver and testis displaying comparatively high levels of expression. Nevertheless, MTF-1 protein levels were found to be significantly elevated in diverse human tumor types, including breast, lung and cervical carcinomas. IHC analysis of a separate panel of fullsize tissue sections of human breast cancers, including tumor and normal adjacent, surrounding tissue, confirmed and extended the results of the TMA analysis. Taken with our previous findings, this new study suggests a role for MTF-1 in human tumor development, growth or spread. Moreover, the study suggests that MTF-1 could be a novel therapeutic target that offers the opportunity to manipulate metal or redox homeostasis in tumor cells. © 2010 Landes Bioscience.

Cite

CITATION STYLE

APA

Shi, Y., Amin, K., Sato, B. G., Samuelsson, S. J., Sambucetti, L., Haroon, Z. A., … Murphy, B. J. (2010). The metal-responsive transcription factor-1 protein is elevated in human tumors. Cancer Biology and Therapy, 9(6), 469–476. https://doi.org/10.4161/cbt.9.6.10979

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free